Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

60%

3 of 5 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A
5(71.4%)
Phase 2
2(28.6%)
7Total
N/A(5)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT04852601Not ApplicableActive Not Recruiting

ToolBox Detect: Low Cost Detection of Cognitive Decline in Primary Care Settings

Role: collaborator

NCT06094491Phase 2Active Not Recruiting

Virtual Diabetes Group Visits Across Health Systems

Role: collaborator

NCT03640312Phase 2Completed

Efficacy and Safety of a Quadruple Ultra-low-dose Treatment for Hypertension

Role: collaborator

NCT04575155Not ApplicableCompleted

Development & Pilot of the Technology-Enabled Alliance for Medication Therapy Management

Role: collaborator

NCT04878562Not ApplicableCompleted

I-COPE Study: Opioid Use and Pain Management in Older Adults

Role: collaborator

NCT03382782Not ApplicableCompleted

Peer Navigators to Address Obesity-Related Concerns for African Americans With Serious Mental Illness

Role: collaborator

NCT01726712Not ApplicableCompleted

Network Supported Engagement In HIV Care

Role: collaborator

All 7 trials loaded